Buscar
Mostrando ítems 1-7 de 7
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease (2020)
(Taylor and Francis Ltd, 2019)
A metabolic perspective of late onset Alzheimer's disease (2020)
(Academic Press, 2019)
Masitinib for the treatment of mild to moderate Alzheimer's disease (2020)
(Expert Reviews Ltd., 2015)